Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune cells and immune mediators represent the collective cellular and molecular elements of the immune system responsible for host defense and tissue homeostasis. This broad category includes various leukocyte populations—such as T cells, B cells, natural killer cells, and macrophages—alongside the signaling molecules they secrete, including cytokines, chemokines, and interferons (StatPearls, 2023; NIH, 2024). These components coordinate complex responses to pathogens, toxins, and malignant cells through intricate signaling networks. In clinical medicine, dysregulation of these mediators is central to the pathogenesis of autoimmune disorders, chronic inflammation, and cancer progression (PubMed, 2023). While many drugs are designed to modulate specific pathways within this system, the term itself describes a functional network rather than a single druggable molecule. Consequently, therapeutic interventions targeting this system must be highly specific to avoid broad-spectrum immunosuppression or off-target inflammatory effects.
Inhibition of cytokine signaling, depletion of specific cell populations, blockade of immune checkpoints, and modulation of intracellular signaling pathways.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cells and immune mediators.